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In the past, only people diagnosed with celiac disease, approximately 1% of the population, avoided gluten consumption through
all their meals. However, popular media often now mistakenly present gluten-free foods as being a healthier choice, and more
people have now concluded that gluten is a harmful part of the diet. A review of literature on gluten-free diets, gluten sensitivity,
celiac disease, and attitudes toward gluten consumption was undertaken to examine the prevalence and consequences of adopting
a gluten-free diet and to provide guidance to healthcare practitioners whose patients are now often adopting this diet without
medical input. Aside from celiac disease, nonceliac gluten sensitivity (NCGS) occurs in those persons in which gluten ingestion
leads to symptomatic manifestations in the absence of celiac disease or wheat allergy but who report a remission of certain
symptoms after removing gluten from their diet. However, it was been shown that a large percentage of people who claim NCGS
do not feel those manifestations under a double-blind challenge to gluten. Moreover, some parents, believing that ingesting gluten
is detrimental for their health, adopt gluten-free diets for their children. A review of existing data shows that there are detrimental
eﬀects to going gluten free, including loss of the dietary ﬁber, deﬁciencies in dietary minerals and vitamins, and potential heavy
metal exposure. Healthcare practitioners should query patients about their dietary choices, and in cases of questionable adoption
of gluten-free diet, patients and parents are educated about the detriments of a gluten-free diet, and in cases where patients
continue to insist on gluten-free foods, referrals to nutritional counseling are warranted in order to minimize potential harm.

1. Increased Popularity of Gluten-Free Diets
There is an increasing body of evidence that a signiﬁcant
proportion of individuals, including not only persons with
celiac disease (CD) or nonceliac gluten sensitivity (NCGS),
are following a gluten-free diet (GFD). “Gluten free” was
deﬁned by the US Food and Drug Administration in 2013 as
foods containing less than 20 parts per million of gluten or
20 mg/kg [1]. In fact, studies ﬁnd that up to 5% of the
population of Western societies report following a GFD of
their own volition, while up to 13% self-report some sensitivity to gluten-containing products [2, 3]. With a GFD
presented in popular media as a healthy diet, many people
who do not have any symptoms after ingesting gluten appear
to be adopting this diet. In the last few years, the popularity
of a GFD has risen steadily in spite of stable rates of CD.
Surprisingly, according to a survey by the NPD Group that

was reported on National Public Radio, almost one-third of
adult Americans say they would prefer to reduce or avoid
gluten consumption altogether [4], compared to an estimated CD prevalence of only 1%. Similarly, a longitudinal
study found that up to 13% of young adults valued glutenfree food, and these individuals were four to seven times
more likely to value food production practices that were
organic, local, non-GMO, and not processed [5]. In short,
many individuals mistakenly believe that a GFD is an inherently healthier choice.

2. What Is Gluten?
Gluten is a high-molecular-weight seed storage protein
commonly found in grass-related grains, such as wheat,
barley, and rye. The natural role of these seed storage
proteins is to nourish seeds during ﬂowering and
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germination, thereby contributing to the successful reproduction of the species [6]. Gluten is a composite protein, composed of glutenin and prolamins, and is also
responsible for the ability of wheat to form dough [7].
Hence, gluten is an integral component of an incredible
variety of wheat-containing foods, including breads, cereals, and pastas.

3. Gluten-Related Disorders: Celiac
Disease versus Nonceliac Gluten Sensitivity
Celiac disease (CD) aﬀects approximately 1% of the
population [8–10] and is an immune-mediated enteropathy most commonly associated with the human serotype
HLA DQ2 or DQ8, with demonstration of small intestinal
villous atrophy and autoantibodies (antitissue transglutaminase and antiendomysal) [11]. When people with CD
ingest gluten, an inﬂammatory process that targets the
intestinal mucosa is triggered, resulting in immune-mediated enteropathy with symptoms that may classically
include malabsorption, diarrhea, steatorrhea, weight loss,
or growth failure [11]. Studies have also suggested that
some CD patients may not suﬀer from the classical gastrointestinal symptoms, but alternatively present with
iron deﬁciency anemia [12], osteoporosis [13], ataxia or
peripheral neuropathy [14], or symptoms that resemble
IBD [15].
Nonceliac gluten sensitivity (NCGS) occurs in those
persons in which gluten ingestion leads to symptomatic
manifestations in the absence of celiac disease or wheat
allergy (WA) but who report a remission of certain symptoms after removing gluten from their diet [16, 17].
Symptoms are related to the gastrointestinal track (abdominal pain, bloating, constipation, and diarrhea) or
extraintestinal (fatigue, headache, joint and muscle pains,
depression, and “foggy mind”) [18, 19]. Despite the name, it
is not clear in many cases of NCGS whether the symptoms
are caused by gluten itself or by other components of the
grains that are consumed [20].
The Salerno Expert’s Criteria provide guidance on how
to test someone for NCGS. It is based on symptoms but
follows a single- or double-blind placebo-controlled challenge [21]. A key element of these criteria is that the gluten
and gluten-free preparations must be indistinguishable to
the patient, which is diﬃcult to achieve since gluten-free
foods are typically detected easily due to diﬀerences in ﬂavor
and/or texture.
Lioneti et al. [22] found that the prevalence of NCGS
after gluten rechallenge is decreased when the Salerno Expert’s Criteria are applied. Their studies found that a high
proportion of patients suspected to have a NCGS did not
have symptoms in response to gluten ingestion when they
were not able to distinguish between foods with or without
gluten. They hypothesized that, in some patients, the
symptoms suﬀered after gluten ingestion may be due to
(among others) (a) psychological anticipation of intolerance
(nocebo eﬀect), (b) the possibility that NCGS may be a
transient disorder, or (c) the methods used in the gluten
challenge procedure.
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4. Placebo and Nocebo Effects
Diagnosis of NCGS is very diﬃcult, mostly because of the
lack of validated diagnostic criteria and the high nocebo and
placebo eﬀects of gluten [23]. The true prevalence of NCGS is
unknown, but several studies suggest that people may be
diagnosed with NCGS when in reality they are not aﬀected
by gluten ingestion. Nocebo eﬀect is often seen in patients
that complain about intestinal or extraintestinal symptoms
after ingesting gluten [21]. In fact, some studies have found
that the placebo-nocebo eﬀect is a key factor in those persons
that report symptoms upon the ingestion of gluten and/or
have been diagnosed with NCGS [24, 25]. Zanini et al. [25]
studied subjects without CD or WA who fulﬁlled the clinical
criteria of NCGS and adopted a GFD. They found that, after
a double-blind gluten challenge, only one-third of patients
still showed symptoms after ingesting gluten. It has been
suggested that other proteins contained in wheat, such as
lectins, agglutinin, or amylase trypsin inhibitors, may be
responsible for triggering an innate immune response and
leading to symptoms after wheat ingestion. Taken together,
the data may indicate that, in many individuals who have not
been conclusively diagnosed, the nocebo eﬀect of gluten
could be a reality, and they are following a GFD without a
bonaﬁde need to avoid gluten. It has even been suggested
that it may be more appropriate to describe these patients as
having “nonceliac wheat sensitivity” or “self-reported
NCGS” in the absence of clinically conﬁrmed gluten insensitivity [20, 26].

5. Physical Manifestations in People
Suffering from NCGS
For those individuals that truly suﬀer from NCGS, the
manifestations can be intestinal or extraintestinal. Intestinal
manifestations include abdominal pain, bloating, and stool
inconsistency, while extraintestinal manifestations can include fatigue, joint and muscle pain, and limb numbness.
Moreover, neuronal manifestations can also present due to
ingestion of gluten in some people. These manifestations
include foggy mind, headache, gluten neuropathy, gluten
encephalopathy, and gluten ataxia [27].

6. Detriments of a Gluten-Free Diet
6.1. High Cost and Inconvenience. Numerous studies have
demonstrated that adherence to a GFD signiﬁcantly increases
the cost of food for adherents, with prices 2 to 3 times greater
than for similar nongluten-free products [28–30]. Over
15.5 billion US dollars were spent on sales of gluten-free foods
in 2016, double the amount spent in 2011, indicating that the
popularity of a GFD continues to grow [31, 32]. In addition to
cost, adherents of a GFD have inherently fewer choices in
foods and may have diﬃculty ﬁnding or complying with a
GFD [33]. Despite the signiﬁcant cost and added inconvenience, healthy individuals that do not have CD or
symptoms after ingesting gluten are increasingly willing to
pay extra money for GF foods due to misplaced beliefs that
those foods will make them healthier and feel better.
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6.2. Nutritional Risks. GFD can lead to nutritional deﬁciencies of macronutrients and micronutrients. Gluten-free
foods, when compared to equivalent wheat-based foods,
show deﬁciencies in minerals, including calcium, iron,
magnesium, and zinc, and in vitamins, including vitamin
B12, folate, and vitamin D, as well as signiﬁcantly reduced
ﬁber [1, 34]. A 2013 study of both recently diagnosed and
long-term celiac patients adhering to a GFD found nutritional deﬁciencies of each of these nutrients in both populations and recommended dietary education for celiac
patients to help alleviate the problem [35]. In addition, as
nonwheat substitutes in a GFD often contain little ﬁber,
adherents of a GFD are at increased risk for constipation.
Notably, some food components known to be detrimental to health are higher in the GFD than in a regular diet.
For example, a GFD increases dietary exposure to arsenic
[36], and the meals tend to have a higher content of hydrogenated and saturated fatty acids and a higher glycemic
index [17, 31, 34]. In general, it has been shown that a GFD is
an unhealthier diet choice than a regular diet for those that
do not have CD.

7. Benefits of a Gluten-Free Diet
For patients diagnosed with CD, a gluten-free diet is the only
treatment. Ingestion of gluten in these genetically predisposed individuals results in a T-cell-mediated immune reaction, leading to villous atrophy and clinical symptoms.
Avoiding gluten prevents this response, and as such, for CD
patients, a gluten-free diet is critical to their well-being.
For suﬀerers of CD, the increase in popularity of a GFD
among the general population has led to dramatically more
selections of foods devoid of gluten, which are likely more
palatable and more likely to be enriched with vitamins and
minerals to meet the demands of an expanded marketplace.
Also, more studies are aimed at ﬁnding those food sources that
are still gluten free but higher in nutrients missing in a GFD.
For individuals who do not suﬀer from CD, beneﬁts of a
GFD are less obvious. The positive outcomes of a nocebo/
placebo eﬀect for those with NCGS, even if it is not the
gluten component of wheat that leads to their symptoms,
cannot be discounted. For some individuals, this may justify
the detriments of a GFD.
The beneﬁts of GFD continue to have an increased interest among researchers and practitioners working on the
improvement of behavior in children with autism and other
spectrum disorders. Even though some research informed
that there was not signiﬁcant evidence of improvement of
functioning in children with autism, GFD was reported as
well tolerated and safe [37]. Lee et al. [38] reported that
modiﬁed gluten-free ketogenic diet with supplemental medium-chain triglycerides (MCT) has a positive treatment
eﬀect on the improvement of behavior in children with autism
spectrum disorder and requires further investigation (p. 2).

8. NCGS in Children
As outlined above, there is a risk of nutritional deﬁciencies
when either adults or children are subject to a GFD. As such,
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it is imperative to have the right diagnosis before placing any
child on a GFD. For children with celiac disease, there is no
other diet to follow than the GFD, yet diagnosis of CD
requires that an individual continue to eat gluten prior to the
diagnosis. After diagnosis, having a diet without gluten will
help those children to heal their intestine and absorb more
nutrients than if they are ingesting gluten.
In children that are diagnosed with NCGS, extra precaution needs to be taken because of the dangers of nutritional deﬁciency and the diﬃculty in achieving an
accurate diagnosis absent a double-blind challenge, which is
not typically achievable through a primary care healthcare
provider. Tanpowpong et al. [39] found that the prevalence
of gluten avoidance is 5 times higher than doctor-diagnosed
celiac disease. Moreover, in a recent clinical trial in children
with gastrointestinal and extra-intestinal symptoms related
to gluten ingestion, it was found in a double-blind placebocontrolled (DBPC) gluten challenge that more than 60% of
suspected cases were ruled out for NCGS diagnosis [19]. This
conﬁrms the need to acknowledge the presence of the
nocebo eﬀect when trying to diagnose NCGS, which could
be as high as 40% [40], supporting the need to use a DBPC to
establish the diagnosis. There is in fact limited data describing pediatric prevalence of NCGS, and its likelihood as a
diagnosis is unclear [19].
Thus, the actual prevalence of NCGS does not appear to
justify the commonality of a GFD in children, given the
potential detriments of a GFD. In fact, there is currently no
evidence to support the imposition of a GFD in asymptomatic children in the absence of CD or documented wheat
allergy [41].

9. Implications for Nursing Practice
9.1. Assessment. It is necessary for pediatricians, nurse
practitioners, and other health professionals working with
children to query parents about their choice of diet for their
children. As a sizable slice of the population has misidentiﬁed
limiting gluten intake as being beneﬁcial to their health, it
seems to follow that those who subscribe to this belief and who
become parents may feel similarly about what their children
eat. It is common during routine exams for healthcare
practitioners to ask about whether kids eat vegetables and
fruits to get a sense of their diet. It is also important to establish whether kids eat grains to determine whether parents
might be unnecessarily limiting their children to a GFD.
Although the long-term health eﬀects of a GFD have not
been established, a systematic review of prior studies has
identiﬁed increased total cholesterol, high density lipoprotein, fasting glycemia, and body mass index as consistent
ﬁndings [36]. Similarly, a recent population-based study
found higher levels of heavy metal accumulation in adherents of a GFD, including higher blood levels of mercury,
cadmium, and lead, as well as increased urine levels of arsenic [42]. Patients who do follow a GFD may therefore need
assessment for clinical manifestations of a variety of nutritional deﬁciencies, including calcium, iron, magnesium,
zinc, vit. B12, vit. D, and folate, as outlined above, as well as
heavy metal toxicity, blood lipids, and glycemic levels.
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9.2. Teaching. For parents of children with CD, it is a
common practice for gastroenterologists and/or nutritionists to consult with parents to teach them the limitations of a
GFD and to ensure that their children not only avoid gluten
but also to teach parents how to secure the nutrients that are
likely to be missing from their child’s diet. Similarly, with the
risk of a GFD in the general population, healthcare practitioners need to proactively question whether their patients,
whether children or adults, are following a gluten-free diet of
their own volition.
If patients, either adults or children, are suﬀering from
symptoms that may be associated with CD, then referral to a
gastroenterologist for proper diagnosis is critical. However,
in the absence of symptoms, or vague descriptions of “gluten
allergy” or other unrecognized disorders, patients who
follow a GFD ﬁrst need education on the true prevalence of
CD and NCGS. They need to be taught of the need to secure
sources of nutrients that may be limited in a GFD, and they
need to know that following a GFD blindly may be harming
themselves or their children. In the end, only persons with
CD, WA, or conﬁrmed NCGS should follow a GFD, and
they should do so under medical supervision.
9.3. Referrals. Adults who self-administer a GFD and cite
physical symptoms should be referred for CD testing. Adults
who do not have CD but continue to insist on a GFD should
be referred for nutritional counseling to ensure they are
meeting their dietary needs and avoiding unnecessary
hazards. Multivitamin/mineral and ﬁber supplements are a
good idea for anyone attempting to avoid gluten to ensure
adequate nutrition and to ensure proper bowel function.
For children who are put on a GFD, often by wellmeaning parents, in the absence of a clinically relevant
diagnosis, it is important that the parent be educated on the
risks of a GFD, the need for CD testing if the parents claim
symptoms in the child, and the potential hazards to their
child of a GFD. If they insist, a referral to nutritional
counseling is warranted.

10. Conclusions
While celiac disease patients must permanently remove
gluten from their diet, the literature suggests that many
individuals who claim to suﬀer from NCGS may in fact have
no actual sensitivity to gluten although it is possible they are
sensitive to other components of wheat. Alternatively, these
individuals may be beneﬁtting from a nocebo/placebo eﬀect
when it comes to adopting a GFD. It is likely, however, that
the majority of persons adopting a GFD have no medical
basis for doing so.
The choice to adopt a GFD is often made by individuals
without medical input, in the belief that they are adopting a
healthier diet. Unfortunately, choosing GFD, irrespective of
whether it is medically indicated, generally entails increased
food costs, a decrease in ﬁber consumption, potential decreases in mineral and vitamin consumption, including calcium, magnesium, zinc, vitamin B12, folate, and vitamin D,
and potentially increased exposure to dietary hydrogenated
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and saturated fatty acids, and arsenic. Clearly, adopting a GFD
does not come without risk.
In the end, only persons with CD, WA, or conﬁrmed
NCGS should follow a GFD, and they should do so under
medical supervision. For individuals who insist on a GFD in
the absence of a diagnosis that suggests its beneﬁts outweighs
its risks, nutritional counseling is recommended to ensure
that these individuals can minimize the risks to themselves
while still choosing the diet they prefer.
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